CART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT03896854 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

BIOLOGICAL: CART-19

Sponsor

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd